The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Funck, Jr. Robert E. since 2014.
This trader's CIK number is 1565892.
At the time of last reporting, Funck, Jr. Robert E. was the EXECUTIVE VICE PRESIDENT of Abbott Laboratories. (stock ticker symbol ABT).
Also see all insider trading activities at Abbott Laboratories.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ABT | 0 | $0 | 10,097 | $1,055,823 | 10,097 | $474,559 |
| 2023 | ABT | 0 | $0 | 1,264 | $127,284 | 0 | $0 |
| 2021 | ABT | 0 | $0 | 0 | $0 | 31,325 | $1,225,434 |
| 2020 | ABT | 0 | $0 | 84,689 | $9,174,581 | 120,033 | $4,558,988 |
| 2019 | ABT | 0 | $0 | 1,002 | $78,156 | 40,000 | $1,397,600 |
| 2018 | ABT | 0 | $0 | 1,220 | $71,970 | 49,200 | $1,250,417 |
| 2017 | ABT | 0 | $0 | 25,500 | $1,160,250 | 25,500 | $680,773 |
| 2016 | ABT | 0 | $0 | 28,133 | $1,206,936 | 26,800 | $676,592 |
| 2015 | ABT | 0 | $0 | 0 | $0 | 36,542 | $786,432 |
| 2014 | ABT | 0 | $0 | 10,811 | $395,275 | 9,398 | $315,049 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-10 | ABT | Option Ex | 10,097 | 47.00 | 474,559 |
| 2024-05-10 | ABT | Sale | 10,097 | 104.57 | 1,055,823 |
| 2023-03-01 | ABT | Sale | 1,264 | 100.70 | 127,284 |
| 2021-02-02 | ABT | Option Ex | 31,325 | 39.12 | 1,225,434 |
| 2020-10-26 | ABT | Sale | 83,333 | 108.83 | 9,068,963 |
| 2020-10-26 | ABT | Option Ex | 83,333 | 38.40 | 3,199,987 |
| 2020-04-21 | ABT | Option Ex | 36,700 | 37.03 | 1,359,001 |
| 2020-03-02 | ABT | Sale | 1,356 | 77.89 | 105,618 |
| 2019-08-09 | ABT | Option Ex | 40,000 | 34.94 | 1,397,600 |
| 2019-03-01 | ABT | Sale | 1,002 | 78.00 | 78,156 |
| 2018-09-05 | ABT | Option Ex | 36,400 | 25.20 | 917,425 |
| 2018-06-05 | ABT | Option Ex | 12,800 | 26.02 | 332,992 |
| 2018-03-01 | ABT | Sale | 1,220 | 58.99 | 71,970 |
| 2017-02-23 | ABT | Option Ex | 25,500 | 26.70 | 680,773 |
| 2017-02-23 | ABT | Sale | 25,500 | 45.50 | 1,160,250 |
| 2016-07-25 | ABT | Option Ex | 26,800 | 25.25 | 676,592 |
| 2016-07-25 | ABT | Sale | 26,800 | 43.08 | 1,154,544 |
| 2016-02-29 | ABT | Sale | 1,333 | 39.30 | 52,392 |
| 2015-07-29 | ABT | Option Ex | 26,000 | 21.22 | 551,694 |
| 2015-02-13 | ABT | Option Ex | 10,542 | 22.27 | 234,738 |
| 2014-03-03 | ABT | Sale | 1,413 | 38.97 | 55,068 |
| 2014-01-31 | ABT | Option Ex | 9,398 | 33.52 | 315,049 |
| 2014-01-31 | ABT | Sale | 9,398 | 36.20 | 340,207 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Funck, Jr. Robert E. (EXECUTIVE VICE PRESIDENT of Abbott Laboratories at the time of this reporting) see the Securities and Exchange Commission (SEC) website.